Nail pigmentation following cancer chemotherapy. A new genetic entity?
D003520:Cyclophosphamide / Q000009:adverse effects*; D004317:Doxorubicin / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology* / Q000235:genetics; D005260:Female; D006801:Humans; D007558:Italy; D008297:Male; D009260:Nail Diseases / Q000139:chemically induced* / Q000235:genetics; D009369:Neoplasms / Q000188:drug therapy*; D010859:Pigmentation Disorders / Q000139:chemically induced* / Q000235:genetics
D004317:Doxorubicin; D003520:Cyclophosphamide